Phoundry Pharmaceuticals Overview
- Year Founded
-
2015
- Status
-
Acquired/Merged
- Latest Deal Type
-
M&A
Phoundry Pharmaceuticals General Information
Description
Owner and operator of a peptide therapeutic company. The company offers services for identification of therapeutically valuable peptide hormone targets and the optimization of peptide ligands to drugs and also discovers peptide therapeutic drugs.
Contact Information
Ownership Status
Acquired/Merged
Financing Status
Formerly Accelerator/Incubator backed
Primary Office
- 6 Davis Drive
- Research Triangle Park
- Durham, NC 27709
- United States
Phoundry Pharmaceuticals Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 3. Merger/Acquisition | 24-Sep-2015 | 00000 | Completed | Startup | ||
| 2. Seed Round | 06-Aug-2015 | 00000 | 00000 | Completed | Startup | |
| 1. Accelerator/Incubator | Completed | Startup |
Phoundry Pharmaceuticals Executive Team (6)
| Name | Title | Board Seat | Contact Info |
|---|---|---|---|
| Paul Feldman Ph.D | Co-Founder, Chief Executive Officer and Board Member | ||
| Andrew Young Ph.D | Co-Founder, Chief Scientific Officer and Board Member |
Phoundry Pharmaceuticals Board Members (1)
| Name | Representing | Role | Since |
|---|---|---|---|
| Paul Feldman Ph.D | Phoundry Pharmaceuticals | Co-Founder, Chief Executive Officer and Board Member | 000 0000 |
Phoundry Pharmaceuticals Former Investors (1)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|---|---|---|---|---|
| Biosciences Accelerator | Accelerator/Incubator | Minority | 000 0000 | 000000 0 |